Chugai Pharma (United States)

40.1k citations
1.7k papers ·

Impact in

Papers in

    • Drug Transport and Resistance Mechanisms 48
    • Bone health and treatments 38
    • Erythropoietin and Anemia Treatment 42

Chugai Pharma (United States)

1.5k papers receiving 36.0k citations

Peers

Chugai Pharma (United States)
Comparison fields: 5 of 212
  • Hematology 3.0k
  • Oncology 6.9k
  • Nephrology 1.6k
  • Immunology 4.8k
  • Pathology and Forensic Medicine 3.6k
Replace Ortho Clinical Diagnostics (United States) with:
Ortho Clinical Diagnostics (United States) United States
Lankenau Medical Center United States
Center for Molecular Medicine and Immunology United States
Incyte (United States) United States
Lankenau Institute for Medical Research United States
Jefferson Institute United States
Nova Medical (United States) United States
Center for Vascular Biology Research United States
Springhouse United States
Eisai (United States) United States
Chugai Pharma (United States) relative to Ortho Clinical Diagnostics (United States) United States Ortho Clinical Diagnostics (United States)'s profile →
Citations per field
00.5×1.5×2.3×
Ortho Clinical Diagnostics (United States) · 1×
Citations per year

Countries citing scholars working at Chugai Pharma (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Chugai Pharma (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Chugai Pharma (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chugai Pharma (United States) more than expected).

Fields of papers published by authors at Chugai Pharma (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Chugai Pharma (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Chugai Pharma (United States) at the time of their publication.

About Chugai Pharma (United States)

In recent decades, authors affiliated with Chugai Pharma (United States) have published 1.7k papers, which have received a total of 40.1k indexed citations . Scholars at this organization have produced 279 papers in Oncology, 114 papers in Hematology, 77 papers in Pharmacology, 180 papers in Immunology and 125 papers in Pathology and Forensic Medicine on the topics of Monoclonal and Polyclonal Antibodies Research (118 papers), Glycosylation and Glycoproteins Research (63 papers), Vitamin D Research Studies (51 papers), Drug Transport and Resistance Mechanisms (48 papers), Protein purification and stability (48 papers), Pharmacogenetics and Drug Metabolism (44 papers), Erythropoietin and Anemia Treatment (42 papers) and Bone health and treatments (38 papers). Their work is cited by papers focused on Hematology (3.0k citations), Oncology (6.9k citations), Nephrology (1.6k citations), Immunology (4.8k citations) and Pathology and Forensic Medicine (3.6k citations). Authors at Chugai Pharma (United States) collaborate with scholars in United States, Japan and United Kingdom and have published in prestigious journals including Chemical and Pharmaceutical Bulletin, The Journal of Antibiotics, EXPERIMENTAL ANIMALS, The Journal of Biochemistry and European Journal of Pharmacology. Some of Chugai Pharma (United States)'s most productive authors include Masahiko Mihara, Yoshiyuki Ohsugi, Misato Hashizume, Kunio Ando, Hiroshi Sasaki, Hideaki Mizuno, Kunihiro Hattori, Kunio Kitada, Akinori Sarai and Kenta Nakai.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact